Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Hemostemix Inc (HMTXF)

Hemostemix Inc (HMTXF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Hemostemix Drives Social Media Awareness of Its Regenerative Medicine Treatments Newsfile - Tue Dec 17, 10:22AM CST

Hemostemix is revolutionizing how individuals think about their own regenerative medicine treatments. With social media, the company is educating about its treatments and advancements.Calgary, Alberta--(Newsfile...

HMTXF : 0.0468 (-0.21%)
HEM.VN : 0.070 (unch)
Hemostemix Announces $2,725,982 Update to Second Closing Newsfile - Tue Dec 3, 3:42PM CST

Calgary, Alberta--(Newsfile Corp. - December 3, 2024) - Hemostemix Inc. (TSXV: HEM) (OTC Pink: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is pleased to announce it is amending its closing documents...

HMTXF : 0.0468 (-0.21%)
HEM.VN : 0.070 (unch)
Hemostemix Announces $2,675,981 Private Placement Including Second Tranche of $833,258 Newsfile - Thu Nov 28, 4:46PM CST

Calgary, Alberta--(Newsfile Corp. - November 28, 2024) - Hemostemix Inc. (TSXV: HEM) (OTC Pink: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is pleased to announce it has closed its second and...

HMTXF : 0.0468 (-0.21%)
HEM.VN : 0.070 (unch)
Hemostemix Announces ACP-01 Treatment-Purchase Available with Social Media Campaign Underway Newsfile - Mon Nov 25, 12:44PM CST

Calgary, Alberta--(Newsfile Corp. - November 25, 2024) - Hemostemix Inc. (TSXV: HEM) (OTC Pink: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is pleased to announce that, focusing on revenue, it...

HMTXF : 0.0468 (-0.21%)
HEM.VN : 0.070 (unch)
Hemostemix Announces the First Tranche Closing of $1.8M of Its Recently Announced Private Placement Newsfile - Thu Oct 31, 3:16PM CDT

Calgary, Alberta--(Newsfile Corp. - October 31, 2024) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is pleased to announce it has closed its first tranche of the...

HMTXF : 0.0468 (-0.21%)
HEM.VN : 0.070 (unch)
Hemostemix's Private Placement Newsfile - Fri Oct 11, 7:44AM CDT

Calgary, Alberta--(Newsfile Corp. - October 11, 2024) - Hemostemix Inc. (TSXV: HEM) (OTC Pink: HMTXF) (FSE: 2VF0) is pleased to announce that the Company is closing up to $4,000,000 of financing in tranches...

HMTXF : 0.0468 (-0.21%)
HEM.VN : 0.070 (unch)
Hemostemix Closes its Funded Manufacturing Services Agreement with CytoImmune, Restarting Production of ACP-01 Newsfile - Thu Aug 1, 9:14PM CDT

Calgary, Alberta--(Newsfile Corp. - August 1, 2024) - Hemostemix Inc. (TSXV: HEM) (OTC Pink: HMTXF) (FSE: 2VF0) is pleased to announce it and CytoImmune Therapuetics ("CytoImmune") today signed a binding...

HMTXF : 0.0468 (-0.21%)
HEM.VN : 0.070 (unch)
Hemostemix Announces Trademark Granted by Switzerland and Interest Payment Newsfile - Tue Jun 11, 10:12AM CDT

Calgary, Alberta--(Newsfile Corp. - June 11, 2024) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) is pleased to announce it was notified by the World Intellectual Property Organization that it...

HMTXF : 0.0468 (-0.21%)
HEM.VN : 0.070 (unch)
Hemostemix Announces Strategic Manufacturing Partnership with CytoImmune Therapeutics and $1,800,000 in Financing Commitments Newsfile - Mon Jun 3, 8:18AM CDT

Calgary, Alberta--(Newsfile Corp. - June 3, 2024) - Hemostemix Inc. (TSXV: HEM) (OTC Pink: HMTXF) (FSE: 2VF0) is pleased to announce it has signed a Letter of Intent ("LOI") with CytoImmune Therapuetics...

HMTXF : 0.0468 (-0.21%)
HEM.VN : 0.070 (unch)
Hemostemix Announces Engagement of Oak Hill Asset Management Inc. Newsfile - Thu Mar 7, 3:06PM CST

Calgary, Alberta--(Newsfile Corp. - March 7, 2024) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is pleased to announce the non-exclusive engagement of Oak Hill...

HMTXF : 0.0468 (-0.21%)
HEM.VN : 0.070 (unch)

Barchart Exclusives

Broadcom Estimates Are Rising, Pushing Up AVGO Stock's Value - Good for OTM Short Put Plays Barchart - 39 minutes ago
Analysts have been hiking Broadcom's revenue estimates, which has raised its value. This is based on Broadcom's strong free cash flow margins. As a result, shorting out-of-the-money (OTM) put options works well here. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot